Signal mining of adverse events of proteasome inhibitors in multiple myeloma based on FAERS
The overall distribution of AEs for the three multiple myeloma proteasome inhibitors was consistent, but there were certain differences in specific AE signal characteristics, which should be noted in clinical applications.
Authors
- Yuying Zhou (ORCID: https://orcid.org/0000-0003-4695-7169)
- Yuan Peng (ORCID: https://orcid.org/0000-0001-9563-9568)
- Yan Zhong (ORCID: https://orcid.org/0000-0001-6344-3157)
- Jia Xu (ORCID: https://orcid.org/0000-0002-2444-8980)
- Kaisen Shu
Institutions
- North Sichuan Medical University (CN)
- Xuzhou Medical College (CN)
- Affiliated Hospital of North Sichuan Medical College (CN)
- Tibet Autonomous Region People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.3389/fphar.2024.1396378
- Citations
- 5
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.27